| Active substance | Erythropoietin  | 
		
|---|---|
| Storage conditions | Refrigerated, typically between 2-8В°C  | 
		
| Side effects | Hypertension, thrombosis, increased risk of stroke, headache, flu-like symptoms  | 
		
| Effects | Increases red blood cell count, enhances oxygen transport and aerobic capacity  | 
		
| Dosage (sports) | Misuse can involve 20-50 IU/kg of body weight, three times per week  | 
		
| Dosage (medical) | Typically 50-300 units/kg three times a week, dose adjusted based on hemoglobin levels and patient response  | 
		
| Half-life | Varies, typically 4-13 hours depending on the type (recombinant forms)  | 
		
| Main action | Stimulates erythropoiesis (production of red blood cells)  | 
		
| Substance class | Hormone, specifically a growth factor  | 
		
| Formula | Not applicable as it is a glycoprotein  | 
		
| Chemical name | Erythropoietin  | 
		
| Trade name | Epogen, Procrit, Eprex, others  | 
		
| Blood pressure | Can cause an increase in blood pressure  | 
		
| WAREHOUSE | International Warehouse 2  | 
		
| Also known as | EPO  | 
		
| Lab Test | Detection via specific blood tests (e.g., EPO doping test, isoelectric focusing)  | 
		
| Aromatization | No  | 
		
| Hepatotoxicity | No  | 
		
| HBR | No  | 
		
| Water Retention | No  | 
		
| Acne | No  | 
		
| Classification | Glycoprotein Cytokine  | 
		
| Use in sports | Banned – used to increase endurance and performance  | 
		
| Manufacturer | Drogsan  | 
		





There are no reviews yet.